C. Younkin

发表

eSNPs within VAMP1 show genetic association with late onset Alzheimer's disease

R. Petersen, D. Dickson, M. Carrasquillo, 2010, Alzheimer's & Dementia.

Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations

Krishna R. Kalari, Jennifer M. Carr, Asha A. Nair, 2012, Front. Oncol..

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

Margaret A. Pericak-Vance, John X. Morris, Jonathan L. Haines, 2012, Neurology.

Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseases

James A. Eddy, Benjamin A. Logsdon, Benjamin D. Heavner, 2016, Scientific Data.

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

Ronald C. Petersen, V. Shane Pankratz, Minerva M. Carrasquillo, 2009, Alzheimer's & Dementia.

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants

Margaret A. Pericak-Vance, Jonathan L. Haines, Ronald C. Petersen, 2012, PLoS genetics.

Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

Manolis Kellis, Bradley E. Bernstein, Matthew L. Eaton, 2014 .

Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

Manolis Kellis, David A Bennett, Towfique Raj, 2014, Nature Neuroscience.

TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease

Cory C. Funk, N. Price, D. Dickson, 2018, The Journal of experimental medicine.

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans

R. Petersen, S. Lincoln, B. Boeve, 2018, Molecular Neurodegeneration.

Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci

G. Schellenberg, N. Price, D. Serie, 2016, Acta Neuropathologica.

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

V. Pankratz, R. Petersen, D. Dickson, 2009, Nature Genetics.

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans

R. Petersen, S. Lincoln, B. Boeve, 2018, Molecular Neurodegeneration.

Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy

Cory C. Funk, N. Price, D. Serie, 2018, Acta Neuropathologica.

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

J. Haines, M. Pericak-Vance, G. Schellenberg, 2014, Alzheimer's Research & Therapy.

A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression

Asha A. Nair, Charles C. White, N. Price, 2016, Alzheimer's & Dementia.

Identification of novel Alzheimer’s disease genes co-expressed with TREM2

Y. Asmann, G. Jenkins, J. Biernacka, 2020, bioRxiv.

Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases

Cory C. Funk, D. Geschwind, N. Price, 2018, Alzheimer's & Dementia.

Late-onset Alzheimer disease risk variants mark brain regulatory loci

D. Serie, Y. Asmann, R. Petersen, 2015, Neurology: Genetics.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

Asha A. Nair, V. Pankratz, R. Petersen, 2012, Molecular Neurodegeneration.

Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease

V. Pankratz, K. Morgan, M. Carrasquillo, 2010, Neurology.

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy

Murray Grossman, Jordan Grafman, Nilüfer Ertekin-Taner, 2015, Nature Communications.

Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease

V. Pankratz, R. Petersen, D. Dickson, 2010, PloS one.

Alzheimer ' s disease : early alterations in brain DNA methylation

S. Gabriel, Manolis Kellis, D. Bennett, 2015 .

Explorer Concordant Association of Insulin Degrading Enzyme Gene ( IDE ) Variants with IDE mRNA , A beta , and Alzheimer ' s Disease

V. Pankratz, R. Petersen, D. Dickson, 2017 .

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

J. Haines, M. Pericak-Vance, G. Schellenberg, 2014, Alzheimer's Research & Therapy.

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

John X. Morris, Jason J. Corneveaux, Asha A. Nair, 2012, Neurology.

Alzheimery's disease pathology is associated with early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci

S. Gabriel, Manolis Kellis, D. Bennett, 2014, Nature neuroscience.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications

Asha A. Nair, V. Pankratz, R. Petersen, 2012, Molecular Neurodegeneration.

Genome-wide exploration of DNA methylation in the aging brain and its relation to Alzheimer's disease

Manolis Kellis, B. Bernstein, S. Younkin, 2012, Alzheimer's & Dementia.